176 related articles for article (PubMed ID: 37245038)
41. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
Shimakawa Y; Veillon P; Birguel J; Pivert A; Sauvage V; Guillou-Guillemette HL; Roger S; Njouom R; Ducancelle A; Amta P; Huraux JM; Adoukara JP; Lunel-Fabiani F
Lancet Glob Health; 2022 Apr; 10(4):e521-e529. PubMed ID: 35183302
[TBL] [Abstract][Full Text] [Related]
42. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
Lu Y; Zhu FC; Liu JX; Zhai XJ; Chang ZJ; Yan L; Wei KP; Zhang X; Zhuang H; Li J
Vaccine; 2017 Dec; 35(48 Pt B):6627-6633. PubMed ID: 29079104
[TBL] [Abstract][Full Text] [Related]
43. Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.
van Schalkwyk J; Nourmoussavi M; Massey A; Gustafson R; Brodkin E; Petric M; Krajden M; Dobson S; Buxton J; Bigham M; Pick N; Schreiber R; Sherlock CH; Money D; Yoshida EM
Can J Gastroenterol Hepatol; 2014 Nov; 28(10):525-8. PubMed ID: 25390612
[TBL] [Abstract][Full Text] [Related]
44. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
[TBL] [Abstract][Full Text] [Related]
45. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.
Wang Z; Zhang J; Yang H; Li X; Wen S; Guo Y; Sun J; Hou J
J Med Virol; 2003 Nov; 71(3):360-6. PubMed ID: 12966540
[TBL] [Abstract][Full Text] [Related]
46. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
[No Abstract] [Full Text] [Related]
47. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
[TBL] [Abstract][Full Text] [Related]
48. Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women.
Lu LL; Chen BX; Wang J; Wang D; Ji Y; Yi HG; Chen T; Zhang Y; Petersen E; Li Q; Qu C
Int J Infect Dis; 2014 Nov; 28():41-4. PubMed ID: 25245000
[TBL] [Abstract][Full Text] [Related]
49. Perinatal transmission of hepatitis B virus: an Australian experience.
Wiseman E; Fraser MA; Holden S; Glass A; Kidson BL; Heron LG; Maley MW; Ayres A; Locarnini SA; Levy MT
Med J Aust; 2009 May; 190(9):489-92. PubMed ID: 19413519
[TBL] [Abstract][Full Text] [Related]
50. Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus.
Hu Y; Chen J; Wen J; Xu C; Zhang S; Xu B; Zhou YH
BMC Pregnancy Childbirth; 2013 May; 13():119. PubMed ID: 23706093
[TBL] [Abstract][Full Text] [Related]
51. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG.
Xu Q; Xiao L; Lu XB; Zhang YX; Cai X
World J Gastroenterol; 2006 Jun; 12(21):3434-7. PubMed ID: 16733865
[TBL] [Abstract][Full Text] [Related]
52. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
[TBL] [Abstract][Full Text] [Related]
53. Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants.
Hsu HY; Chen HL; Chiang CL; Lai MW; Mu SC; Wen WH; Cheng SW; Hu JJ; Chang KC; Lee CN; Liu CJ; Wu JF; Ni YH; Chang MH;
Clin Infect Dis; 2023 Feb; 76(3):e783-e790. PubMed ID: 35789261
[TBL] [Abstract][Full Text] [Related]
54. Chronic HBV infection among pregnant women and their infants in Shenyang, China.
Ding Y; Sheng Q; Ma L; Dou X
Virol J; 2013 Jan; 10():17. PubMed ID: 23294983
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
Xu J; Tao LL; Ma LX
J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
[TBL] [Abstract][Full Text] [Related]
56. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
[TBL] [Abstract][Full Text] [Related]
57. [Clinical observation of telbivudine's antiviral efficacy and protection against mother-to-infant transmission of chronic hepatitis B during the first trimester of pregnancy].
Chen C; Tu X; Cheng Q; Chen F; Dai Y; Gong F; Lin X
Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):9-12. PubMed ID: 25751379
[TBL] [Abstract][Full Text] [Related]
58. [Correlation between serum HBV DNA level and HBsAg titer in HBeAg-positive pregnant women and impact of genomic variability of hepatitis B virus pre S/S regions on their correlations].
Zhang X; Yan L; Lu Y; Wei KP; Liu ZX; Xiao YW; Ding F; Zhuang H; Li J
Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):579-584. PubMed ID: 30317788
[No Abstract] [Full Text] [Related]
59. Quantitative Hepatitis B Surface Antigen Predicts Hepatitis B Transmission in Infants Born to e Antigen-positive Mothers.
Peng S; Wan Z; Liu T; Wang Y; Chen H; Li X; Du Y
J Clin Gastroenterol; 2020 Jan; 54(1):76-82. PubMed ID: 30575631
[TBL] [Abstract][Full Text] [Related]
60. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis.
Boucheron P; Lu Y; Yoshida K; Zhao T; Funk AL; Lunel-Fabiani F; Guingané A; Tuaillon E; van Holten J; Chou R; Bulterys M; Shimakawa Y
Lancet Infect Dis; 2021 Jan; 21(1):85-96. PubMed ID: 32805201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
